{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,26]],"date-time":"2026-04-26T22:46:34Z","timestamp":1777243594245,"version":"3.51.4"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2011,10,1]],"date-time":"2011-10-01T00:00:00Z","timestamp":1317427200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cerebellum"],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1007\/s12311-011-0316-8","type":"journal-article","created":{"date-parts":[[2011,9,30]],"date-time":"2011-09-30T13:07:46Z","timestamp":1317388066000},"page":"488-504","source":"Crossref","is-referenced-by-count":112,"title":["Ataxia Rating Scales\u2014Psychometric Profiles, Natural History and Their Application in Clinical Trials"],"prefix":"10.1007","volume":"11","author":[{"name":"On behalf of the Iberoamerican Multidisciplinary Network for the Study of Movement Disorders (RIBERMOV) Study Group","sequence":"first","affiliation":[]},{"given":"Jonas Alex Morales","family":"Saute","sequence":"first","affiliation":[]},{"given":"Karina Carvalho","family":"Donis","sequence":"additional","affiliation":[]},{"given":"Carmen","family":"Serrano-Munuera","sequence":"additional","affiliation":[]},{"given":"David","family":"Genis","sequence":"additional","affiliation":[]},{"given":"Lu\u00eds Torres","family":"Ramirez","sequence":"additional","affiliation":[]},{"given":"Pilar","family":"Mazzetti","sequence":"additional","affiliation":[]},{"given":"Luis Vel\u00e1zquez","family":"P\u00e9rez","sequence":"additional","affiliation":[]},{"given":"Pilar","family":"Latorre","sequence":"additional","affiliation":[]},{"given":"Jorge","family":"Sequeiros","sequence":"additional","affiliation":[]},{"given":"Antoni","family":"Matilla-Due\u00f1as","sequence":"additional","affiliation":[]},{"given":"Laura Bannach","family":"Jardim","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2011,10,1]]},"reference":[{"key":"316_CR1","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/S1474-4422(09)70305-9","volume":"9","author":"T Klockgether","year":"2010","unstructured":"Klockgether T. Sporadic ataxia with adult onset: classification and diagnostic criteria. Lancet Neurol. 2010;9:94\u2013104.","journal-title":"Lancet Neurol"},{"key":"316_CR2","doi-asserted-by":"crossref","first-page":"E2","DOI":"10.1038\/ncpneuro0503","volume":"3","author":"C Kieling","year":"2007","unstructured":"Kieling C, Morales Saute JA, Jardim LB. When ataxia is not just ataxia. Nat Clin Pract Neurol. 2007;3:E2.","journal-title":"Nat Clin Pract Neurol"},{"key":"316_CR3","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0022-510X(96)00231-6","volume":"145","author":"P Trouillas","year":"1997","unstructured":"Trouillas P, Takayanagi T, Hallett M, Currier RD, Subramony SH, Wessel K, et al. International Cooperative Ataxia Rating Scale for pharmacological assessment of the cerebellar syndrome. The Ataxia Neuropharmacology Committee of the World Federation of Neurology. J Neurol Sci. 1997;145:205\u201311.","journal-title":"J Neurol Sci"},{"key":"316_CR4","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1002\/mds.10290","volume":"17","author":"F Tison","year":"2002","unstructured":"Tison F, Yekhlef F, Balestre E, Chrysostome V, Quinn N, Wenning, et al. Application of the International Cooperative Ataxia Scale rating in multiple system atrophy. Mov Disord. 2002;17:1248\u201354.","journal-title":"Mov Disord"},{"key":"316_CR5","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1002\/mds.10657","volume":"19","author":"E Storey","year":"2004","unstructured":"Storey E, Tuck K, Hester R, Hughes A, Churchyard A. Inter-rater reliability of the International Cooperative Ataxia Rating Scale (ICARS). Mov Disord. 2004;19:190\u20132.","journal-title":"Mov Disord"},{"key":"316_CR6","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1002\/mds.20781","volume":"21","author":"T Schmitz-H\u00fcbsch","year":"2006","unstructured":"Schmitz-H\u00fcbsch T, Tezenas du Montcel S, Baliko L, Boesch S, Bonato S, Fancellu R, et al. Reliability and validity of the International Cooperative Ataxia Rating Scale: a study in 156 spinocerebellar ataxia patients. Mov Disord. 2006;21:699\u2013704.","journal-title":"Mov Disord"},{"key":"316_CR7","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1002\/mds.21735","volume":"22","author":"A D\u2019Abreu","year":"2007","unstructured":"D\u2019Abreu A, Franca Jr M, Lopes-Cendes I, Cendes F. The international cooperative ataxia rating scale in Machado\u2013Joseph disease. Comparison with the unified multiple system atrophy rating scale. Mov Disord. 2007;22:1976\u20139.","journal-title":"Mov Disord"},{"key":"316_CR8","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1002\/mds.22660","volume":"24","author":"K B\u00fcrk","year":"2009","unstructured":"B\u00fcrk K, M\u00e4lzig U, Wolf S, Heck S, Dimitriadis K, Schmitz-H\u00fcbsch T, et al. Comparison of three clinical rating scales in Friedreich ataxia (FRDA). Mov Disord. 2009;24:1779\u201384.","journal-title":"Mov Disord"},{"key":"316_CR9","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1136\/jnnp.2006.096008","volume":"78","author":"MC Fahey","year":"2007","unstructured":"Fahey MC, Corben L, Collins V, Churchyard AJ, Delatycki MB. How is disease progress in Friedreich\u2019s ataxia best measured? A study of four rating scales. J Neurol Neurosurg Psychiatry. 2007;78:411.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"316_CR10","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1002\/mds.22627","volume":"24","author":"MC Fran\u00e7a Jr","year":"2009","unstructured":"Fran\u00e7a Jr MC, D\u2019Abreu A, Nucci A, Cendes F, Lopes-Cendes I. Progression of ataxia in patients with Machado\u2013Joseph disease. Mov Disord. 2009;24:1387\u201390.","journal-title":"Mov Disord"},{"key":"316_CR11","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/S1474-4422(07)70220-X","volume":"6","author":"NA Prospero Di","year":"2007","unstructured":"Di Prospero NA, Baker A, Jeffries N, Fischbeck KH. Neurological effects of high-dose idebenone in patients with Friedreich\u2019s ataxia: a randomised, placebo-controlled trial. Lancet Neurol. 2007;6:878\u201386.","journal-title":"Lancet Neurol."},{"key":"316_CR12","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1001\/archneurol.2010.168","volume":"67","author":"DR Lynch","year":"2010","unstructured":"Lynch DR, Perlman SL, Meier T. A phase 3, double-blind, placebo-controlled trial of idebenone in Friedreich ataxia. Arch Neurol. 2010;67:941\u20137.","journal-title":"Arch Neurol"},{"key":"316_CR13","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1212\/WNL.0b013e3181d31e23","volume":"74","author":"G Ristori","year":"2010","unstructured":"Ristori G, Romano S, Visconti A, Cannoni S, Spadaro M, Frontali M, et al. Riluzole in cerebellar ataxia: a randomized, double-blind, placebo-controlled pilot trial. Neurology. 2010;74:839\u201345.","journal-title":"Neurology"},{"key":"316_CR14","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1007\/s00415-003-1061-9","volume":"250","author":"JC Bier","year":"2003","unstructured":"Bier JC, Dethy S, Hildebrand J, Jacquy J, Manto M, Martin JJ, et al. Effects of the oral form of ondansetron on cerebellar dysfunction. A multi-center double-blind study. J Neurol. 2003;250:693\u20137.","journal-title":"J Neurol"},{"key":"316_CR15","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0022-510X(02)00009-6","volume":"195","author":"M Mori","year":"2002","unstructured":"Mori M, Adachi Y, Mori N, Kurihara S, Kashiwaya Y, Kusumi M, et al. Double-blind crossover study of branched-chain amino acid therapy in patients with spinocerebellar degeneration. J Neurol Sci. 2002;195:149\u201352.","journal-title":"J Neurol Sci"},{"key":"316_CR16","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.jns.2008.03.016","volume":"271","author":"JH Heo","year":"2008","unstructured":"Heo JH, Lee ST, Chu K, Kim M. The efficacy of combined estrogen and buspirone treatment in olivopontocerebellar atrophy. J Neurol Sci. 2008;271:87\u201390.","journal-title":"J Neurol Sci"},{"key":"316_CR17","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.jns.2007.04.019","volume":"260","author":"M Assadi","year":"2007","unstructured":"Assadi M, Campellone JV, Janson CG, Veloski JJ, Schwartzman RJ, Leone P. Treatment of spinocerebellar ataxia with buspirone. J Neurol Sci. 2007;260:143\u20136.","journal-title":"J Neurol Sci"},{"key":"316_CR18","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1111\/j.1468-1331.2008.02318.x","volume":"15","author":"JM Cooper","year":"2008","unstructured":"Cooper JM, Korlipara LV, Hart PE, Bradley JL, Schapira AH. Coenzyme Q10 and vitamin E deficiency in Friedreich\u2019s ataxia: predictor of efficacy of vitamin E and coenzyme Q10 therapy. Eur J Neurol. 2008;15:1371\u20139.","journal-title":"Eur J Neurol"},{"key":"316_CR19","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1212\/01.WNL.0000055872.50364.FC","volume":"60","author":"C Mariotti","year":"2003","unstructured":"Mariotti C, Solari A, Torta D, Marano L, Fiorentini C, Di Donato S. Idebenone treatment in Friedreich patients: 1-year-long randomized placebo-controlled trial. Neurology. 2003;60:1676\u20139.","journal-title":"Neurology"},{"key":"316_CR20","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0304-3940(01)01892-4","volume":"306","author":"L Sch\u00f6ls","year":"2001","unstructured":"Sch\u00f6ls L, Vorgerd M, Schillings M, Skipka G, Zange J. Idebenone in patients with Friedreich ataxia. Neurosci Lett. 2001;306:169\u201372.","journal-title":"Neurosci Lett"},{"key":"316_CR21","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1212\/01.wnl.0000219042.60538.92","volume":"66","author":"T Schmitz-H\u00fcbsch","year":"2006","unstructured":"Schmitz-H\u00fcbsch T, du Montcel ST, Baliko L, Berciano J, Boesch S, Depondt C, et al. Scale for the assessment and rating of ataxia: development of a new clinical scale. Neurology. 2006;66:1717\u201320.","journal-title":"Neurology"},{"key":"316_CR22","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1590\/S0004-282X2010000200014","volume":"68","author":"P Braga-Neto","year":"2010","unstructured":"Braga-Neto P, Godeiro-Junior C, Dutra LA, Pedroso JL, Barsottini OG. Translation and validation into Brazilian version of the Scale of the Assessment and Rating of Ataxia (SARA). Arq Neuropsiquiatr. 2010;68:228\u201330.","journal-title":"Arq Neuropsiquiatr"},{"key":"316_CR23","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1002\/mds.21544","volume":"22","author":"A Weyer","year":"2007","unstructured":"Weyer A, Abele M, Schmitz-H\u00fcbsch T, Schoch B, Frings M, Timmann D, et al. Reliability and validity of the scale for the assessment and rating of ataxia: a study in 64 ataxia patients. Mov Disord. 2007;22:1633\u20137.","journal-title":"Mov Disord"},{"key":"316_CR24","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1212\/WNL.0b013e3181d1a6c9","volume":"74","author":"T Schmitz-H\u00fcbsch","year":"2010","unstructured":"Schmitz-H\u00fcbsch T, Fimmers R, Rakowicz M, Rola R, Zdzienicka E, Fancellu R, et al. Responsiveness of different rating instruments in spinocerebellar ataxia patients. Neurology. 2010;74:678\u201384.","journal-title":"Neurology"},{"key":"316_CR25","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1002\/mds.23531","volume":"26","author":"E Chan","year":"2011","unstructured":"Chan E, Charles P, Ribai P, Goizet C, Marelli C, Vincitorio CM, et al. Quantitative assessment of the evolution of cerebellar signs in spinocerebellar ataxias. Mov Disord. 2011;26:534\u20138. doi: 10.1002\/mds.23531 .","journal-title":"Mov Disord"},{"key":"316_CR26","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1111\/j.1600-0404.2007.00912.x","volume":"116","author":"J Gazulla","year":"2007","unstructured":"Gazulla J, Benavente I. Single-blind, placebo-controlled pilot study of pregabalin for ataxia in cortical cerebellar atrophy. Acta Neurol Scand. 2007;116:235\u20138.","journal-title":"Acta Neurol Scand"},{"key":"316_CR27","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1002\/mds.22681","volume":"24","author":"JD Schmahmann","year":"2009","unstructured":"Schmahmann JD, Gardner R, MacMore J, Vangel MG. Development of a brief ataxia rating scale (BARS) based on a modified form of the ICARS. Mov Disord. 2009;24:1820\u20138.","journal-title":"Mov Disord"},{"key":"316_CR28","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1002\/mds.20255","volume":"19","author":"GK Wenning","year":"2004","unstructured":"Wenning GK, Tison F, Seppi K, Sampaio C, Diem A, Yekhlef F, et al. Multiple System Atrophy Study Group. Development and validation of the Unified Multiple System Atrophy Rating Scale (UMSARS). Mov Disord. 2004;19:1391\u2013402.","journal-title":"Mov Disord"},{"key":"316_CR29","first-page":"152","volume-title":"Third symposium on Parkinson\u2019s disease","author":"R Schwab","year":"1969","unstructured":"Schwab R, England A. Projection technique for evaluating surgery in Parkinson\u2019s disease. In: Gillingham F, Donaldson I, editors. Third symposium on Parkinson\u2019s disease. Edinburgh: Livingstone; 1969. p. 152\u201375."},{"key":"316_CR30","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1007\/s00702-005-0328-y","volume":"112","author":"F Geser","year":"2005","unstructured":"Geser F, Seppi K, Stampfer-Kountchev M, K\u00f6llensperger M, Diem A, Ndayisaba JP, et al. The European Multiple System Atrophy-Study Group (EMSA-SG). J Neural Transm. 2005;112:1677\u201386.","journal-title":"J Neural Transm"},{"key":"316_CR31","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1002\/mds.20678","volume":"21","author":"F Geser","year":"2006","unstructured":"Geser F, Wenning GK, Seppi K, Stampfer-Kountchev M, Scherfler C, Sawires M, et al. Progression of multiple system atrophy (MSA): a prospective natural history study by the European MSA Study Group (EMSA SG). Mov Disord. 2006;21:179\u201386.","journal-title":"Mov Disord"},{"key":"316_CR32","doi-asserted-by":"crossref","first-page":"2371","DOI":"10.1002\/mds.21734","volume":"22","author":"S May","year":"2007","unstructured":"May S, Gilman S, Sowell BB, Thomas RG, Stern MB, Colcher A, et al. Potential outcome measures and trial design issues for multiple system atrophy. Mov Disord. 2007;22:2371\u20137.","journal-title":"Mov Disord"},{"key":"316_CR33","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/mds.22732","volume":"25","author":"R Dodel","year":"2010","unstructured":"Dodel R, Spottke A, Gerhard A, Reuss A, Reinecker S, Schimke N, et al. Minocycline 1-year therapy in multiple-system-atrophy: effect on clinical symptoms and [(11)C] (R)-PK11195 PET (MEMSA-trial). Mov Disord. 2010;25:97\u2013107.","journal-title":"Mov Disord"},{"key":"316_CR34","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1002\/mds.21501","volume":"22","author":"B Holmberg","year":"2007","unstructured":"Holmberg B, Johansson JO, Poewe W, Wenning G, Quinn NP, Mathias C, et al. Safety and tolerability of growth hormone therapy in multiple system atrophy: a double-blind, placebo-controlled study. Mov Disord. 2007;22:1138\u201344.","journal-title":"Mov Disord"},{"key":"316_CR35","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1212\/01.WNL.0000156802.15466.79","volume":"64","author":"SH Subramony","year":"2005","unstructured":"Subramony SH, May W, Lynch D, Gomez C, Fischbeck K, Hallett M, et al. Measuring Friedreich ataxia: interrater reliability of a neurologic rating scale. Neurology. 2005;64:1261\u20132.","journal-title":"Neurology"},{"key":"316_CR36","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1212\/01.wnl.0000218155.46739.90","volume":"66","author":"DR Lynch","year":"2006","unstructured":"Lynch DR, Farmer JM, Tsou AY, Perlman S, Subramony SH, Gomez CM, et al. Measuring Friedreich ataxia: complementary features of examination and performance measures. Neurology. 2006;66:1711\u20136.","journal-title":"Neurology"},{"issue":"4","key":"316_CR37","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1002\/mds.22912","volume":"25","author":"LS Friedman","year":"2010","unstructured":"Friedman LS, Farmer JM, Perlman S, Wilmot G, Gomez CM, Bushara KO, et al. Measuring the rate of progression in Friedreich ataxia: implications for clinical trial design. Mov Disord. 2010;25(4):426\u201332.","journal-title":"Mov Disord"},{"key":"316_CR38","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/j.1468-1331.2008.02078.x","volume":"15","author":"C Kieling","year":"2008","unstructured":"Kieling C, Rieder CR, Silva AC, Saute JA, Cecchin CR, Monte TL, et al. A neurological examination score for the assessment of spinocerebellar ataxia 3 (SCA3). Eur J Neurol. 2008;15:371\u20136.","journal-title":"Eur J Neurol"},{"key":"316_CR39","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s12311-010-0179-4","volume":"9","author":"LB Jardim","year":"2010","unstructured":"Jardim LB, Hauser L, Kieling C, Saute JA, Xavier R, Rieder CR, et al. Progression rate of neurological deficits in a 10-year cohort of SCA3 patients. Cerebellum. 2010;9:419\u201328.","journal-title":"Cerebellum"},{"key":"316_CR40","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1212\/01.wnl.0000325057.33666.72","volume":"71","author":"T Schmitz-H\u00fcbsch","year":"2008","unstructured":"Schmitz-H\u00fcbsch T, Coudert M, Bauer P, Giunti P, Globas C, Baliko L, et al. Spinocerebellar ataxia types 1, 2, 3, and 6: disease severity and nonataxia symptoms. Neurology. 2008;71:982\u20139.","journal-title":"Neurology"},{"issue":"5","key":"316_CR41","first-page":"725","volume":"21","author":"C Despr\u00e9s","year":"2000","unstructured":"Despr\u00e9s C, Lamoureux D, Beuter A. Standardization of a neuromotor test battery: the CATSYS system. Neurotoxicology. 2000;21(5):725\u201335.","journal-title":"Neurotoxicology"},{"issue":"5","key":"316_CR42","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1002\/ajmg.a.32211","volume":"146A","author":"D Aguilar","year":"2008","unstructured":"Aguilar D, Sigford KE, Soontarapornchai K, Nguyen DV, Adams PE, Yuhas JM, et al. A quantitative assessment of tremor and ataxia in FMR1 premutation carriers using CATSYS. Am J Med Genet A. 2008;146A(5):629\u201335.","journal-title":"Am J Med Genet A"},{"issue":"5","key":"316_CR43","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1136\/jmg.2007.054676","volume":"45","author":"EG Allen","year":"2008","unstructured":"Allen EG, Juncos J, Letz R, Rusin M, Hamilton D, Novak G, et al. Detection of early FXTAS motor symptoms using the CATSYS computerised neuromotor test battery. J Med Genet. 2008;45(5):290\u20137.","journal-title":"J Med Genet"},{"issue":"2","key":"316_CR44","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s10048-010-0270-5","volume":"12","author":"JL Juncos","year":"2011","unstructured":"Juncos JL, Lazarus JT, Graves-Allen E, Shubeck L, Rusin M, Novak G, et al. New clinical findings in the fragile X-associated tremor ataxia syndrome (FXTAS). Neurogenetics. 2011;12(2):123\u201335.","journal-title":"Neurogenetics"},{"issue":"1\u20132","key":"316_CR45","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.jns.2007.11.016","volume":"268","author":"M Assadi","year":"2008","unstructured":"Assadi M, Leone P, Veloski JJ, Schwartzman RJ, Janson CG, Campellone JV. Validating an Ataxia Functional Composite Scale in spinocerebellar ataxia. J Neurol Sci. 2008;268(1\u20132):136\u20139.","journal-title":"J Neurol Sci"},{"key":"316_CR46","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1093\/brain\/awn059","volume":"131","author":"ST Montcel du","year":"2008","unstructured":"du Montcel ST, Charles P, Ribai P, Goizet C, Le Bayon A, Labauge P, et al. Composite cerebellar functional severity score: validation of a quantitative score of cerebellar impairment. Brain. 2008;131:1352\u201361.","journal-title":"Brain"},{"key":"316_CR47","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1212\/01.wnl.0000324863.76290.19","volume":"71","author":"T Schmitz-H\u00fcbsch","year":"2008","unstructured":"Schmitz-H\u00fcbsch T, Giunti P, Stephenson DA, Globas C, Baliko L, Sacc\u00e0 F, et al. SCA Functional Index: a useful compound performance measure for spinocerebellar ataxia. Neurology. 2008;71:486\u201392.","journal-title":"Neurology"},{"key":"316_CR48","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1002\/mds.22420","volume":"24","author":"SJ Cano","year":"2009","unstructured":"Cano SJ, Riazi A, Schapira AH, Cooper JM, Hobart JC. Friedreich\u2019s ataxia impact scale: a new measure striving to provide the flexibility required by today\u2019s studies. Mov Disord. 2009;24:984\u201392.","journal-title":"Mov Disord"},{"key":"316_CR49","doi-asserted-by":"crossref","DOI":"10.1093\/acprof:oso\/9780199231881.001.0001","volume-title":"Health measurement scales: a practical guide to their development and use","author":"DL Streiner","year":"2008","unstructured":"Streiner DL, Norman GR. Health measurement scales: a practical guide to their development and use. Oxford: Oxford University Press; 2008."},{"issue":"3","key":"316_CR50","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1111\/j.1532-5415.2008.02122.x","volume":"57","author":"FJ Molnar","year":"2009","unstructured":"Molnar FJ, Man-Son-Hing M, Fergusson D. Systematic review of measures of clinical significance employed in randomized controlled trials of drugs for dementia. J Am Geriatr Soc. 2009;57(3):536\u201346.","journal-title":"J Am Geriatr Soc"},{"key":"316_CR51","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/ncpneuro0446","volume":"3","author":"SM Pulst","year":"2007","unstructured":"Pulst SM. Ataxia rating scales in the balance. Nat Clin Pract Neurol. 2007;3:119.","journal-title":"Nat Clin Pract Neurol"}],"container-title":["The Cerebellum"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12311-011-0316-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12311-011-0316-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12311-011-0316-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T03:53:57Z","timestamp":1559447637000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12311-011-0316-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10,1]]},"references-count":51,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,6]]}},"alternative-id":["316"],"URL":"https:\/\/doi.org\/10.1007\/s12311-011-0316-8","relation":{},"ISSN":["1473-4222","1473-4230"],"issn-type":[{"value":"1473-4222","type":"print"},{"value":"1473-4230","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,10,1]]}}}